These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5901909)

  • 1. Pathological fibrinolytic states and their treatment with epsilon aminocaproic acid (EACA).
    McNicol GP; Browne MK; Bayley C; Douglas AS
    Br J Surg; 1966 Jan; 53(1):26-9. PubMed ID: 5901909
    [No Abstract]   [Full Text] [Related]  

  • 2. Epsilon-aminocaproic acid (EACA).
    Griffin JD; Ellman L
    Semin Thromb Hemost; 1978; 5(1):27-40. PubMed ID: 568312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of skeletal hemangioma and Kasabach-Merritt syndrome with aminocaproic acid. Is fibrinolysis "defensive"?
    Neidhart JA; Roach RW
    Am J Med; 1982 Sep; 73(3):434-8. PubMed ID: 7124770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epsilon aminocaproic acid.
    Br Med J; 1967 Dec; 4(5581):725-6. PubMed ID: 6070179
    [No Abstract]   [Full Text] [Related]  

  • 5. [FIBRINOLYSIS AND EPSILON-AMINOCAPROIC ACID].
    MARCHAL G; BILSKI-PASQUIER G; SAMAMA M
    Hemostase; 1964 Mar; 4():95-101. PubMed ID: 14188681
    [No Abstract]   [Full Text] [Related]  

  • 6. I. Evidence that a hypercoagulable state precedes massive oozing during and after major surgery. II. Effect of epsilon-aminocaproic acid (EACA) in control of surgical oozing.
    Cliffton EE
    Bibl Haematol; 1965; 23():1264-77. PubMed ID: 5885215
    [No Abstract]   [Full Text] [Related]  

  • 7. Epsilon-aminocaproic acid in preoperative correction of haemostatic defect in cyanotic congenital heart-disease.
    Gralnick HR
    Lancet; 1970 Jun; 1(7658):1204-5. PubMed ID: 4192381
    [No Abstract]   [Full Text] [Related]  

  • 8. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
    Schwartz BS; Williams EC; Conlan MG; Mosher DF
    Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPSILON-AMINOCAPROIC ACID (EACA).
    NAHUM LH
    Conn Med; 1964 Sep; 28():641-5. PubMed ID: 14201313
    [No Abstract]   [Full Text] [Related]  

  • 10. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of epsilon-aminocaproic acid on the mineralocorticoid hypertension of the rat.
    Hartig F; Sponer G; Bartsch W; von Möllendorf E
    Exp Pathol; 1981; 19(4):199-205. PubMed ID: 7250299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of fibrin stabilizing factor: report of a case, probably congenital, with observations on the effects of treatment with -aminocaproic acid and with prednisone.
    Stefanini M; Ewbank RL; Andracki EG
    Am J Clin Pathol; 1972 Mar; 57(3):364-8. PubMed ID: 5018606
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA) ON BLOOD COAGULATION TIME].
    GAERTNER H; LISIEWICZ J; SIEROSLAWSKI H; SZIRMAI E
    Acta Med Okayama (1952); 1963 Jun; 17():123-6. PubMed ID: 14121937
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of epsilon-aminocaproic acid during peritoneal dialysis.
    Fish SS; Pancorbo S; Berkseth R
    J Neurosurg; 1981 Jun; 54(6):736-9. PubMed ID: 7241183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EPSILON-AMINOCAPROIC ACID AND FIBRINOLYSIS].
    VAIREL E; LANDE M; LEGER L
    Presse Med (1893); 1964 Mar; 72():945-6. PubMed ID: 14119753
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolysis in congenital heart disease. Preoperative treatment with epsilon-aminocaproic acid.
    Brodsky I; Gill DN; Lusch CJ
    Am J Clin Pathol; 1969 Jan; 51(1):51-7. PubMed ID: 5766110
    [No Abstract]   [Full Text] [Related]  

  • 18. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of the fibrinolytic inhibitor epsilon-aminocaproic acid on the incidence of deep-vein thrombosis after prostatectomy.
    Gordon-Smith IC; Hickman JA; el-Masri SH
    Br J Surg; 1972 Jul; 59(7):522-4. PubMed ID: 5041103
    [No Abstract]   [Full Text] [Related]  

  • 20. EFFECTS OF EPSILON AMINO CAPROIC ACID (EACA) ON SURVIVAL OF FIBRINOGEN I-131 AND ON FIBRINOLYTIC AND COAGULATION FACTORS IN DOGS.
    LEWIS JH
    Proc Soc Exp Biol Med; 1963 Dec; 114():777-8. PubMed ID: 14120347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.